Form 4 Tracker
Vir Biotechnology, Inc.
VIR

20 insider filings · Latest: May 1, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 24, 2025Feb 25 1:40 AMVanina de Verneuil
Proposed Sale
5,140$9.45$48.6K

View →

Feb 24, 2025Feb 25 1:38 AMMarianne De Backer
Proposed Sale
16,122$9.45$152.4K

View →

Feb 18, 2025Feb 19 12:50 AMGeorge Scangos
Proposed Sale
10,964$9.81$107.6K

View →

Feb 13, 2025Feb 13 11:49 PMBrent Sabatini
Proposed Sale
1,562$9.15$14.3K

View →

Jan 8, 2025Jan 8 9:22 PMVICKI LEE SATO
Proposed Sale
43,840$7.89$345.9K

View →

Dec 2, 2024Dec 2 10:08 PMVANINA ALEXANDRA HUARD DE VERNEUIL
Proposed Sale
76$8.22$625

View →

Nov 6, 2024Nov 6 9:55 PMVANINA DE VERNEUIL
Proposed Sale
4,397$9.64$42.4K

View →

Nov 5, 2024Nov 5 9:23 PMVANINA DE VERNEUIL
Proposed Sale
2,347$9.37$22.0K

View →

Sep 9, 2024Sep 9 8:29 PMJANET ANN NAPOLITANO
Proposed Sale
12,190$7.76$94.6K

View →

← Previous

Page 4 of 4

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 24, 2026Feb 26 9:56 PMVicki L SatoDirector
Option Exercise
42,377$1.490(D)

View →

Feb 22, 2026Feb 25 12:13 AMBrent SabatiniSVP, Chief Accounting Officer
Grant/Award
50,000$7.5650,000(D)

View →

Feb 22, 2026Feb 25 12:12 AMJason O'ByrneEVP & Chief Financial Officer
Grant/Award
110,000$7.56110,000(D)

View →

Feb 22, 2026Feb 25 12:11 AMMark EisnerEVP and Chief Medical Officer
Grant/Award
110,000$7.56110,000(D)

View →

Feb 22, 2026Feb 25 12:10 AMVerneuil Vanina deEVP, General Counsel, Corp Sec
Grant/Award
110,000$7.56110,000(D)

View →

Feb 22, 2026Feb 25 12:09 AMBacker Marianne DeDirector, Chief Executive Officer
Grant/Award
570,000$7.56570,000(D)

View →